HKD 7.2
(-0.69%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 88.29 Million CNY | 8.04% |
2022 | 81.72 Million CNY | -50.97% |
2021 | 166.67 Million CNY | 13.97% |
2020 | 146.24 Million CNY | 86.35% |
2019 | 78.47 Million CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 34.8 Million CNY | 0.0% |
2024 Q1 | 34.8 Million CNY | 202.73% |
2023 FY | 88.29 Million CNY | 8.04% |
2023 Q1 | 32.64 Million CNY | 277.3% |
2023 Q4 | 11.49 Million CNY | 0.0% |
2023 Q3 | 11.49 Million HKD | -64.78% |
2023 Q2 | 32.64 Million CNY | 0.0% |
2022 Q2 | 32.2 Million CNY | 0.0% |
2022 Q1 | 32.2 Million CNY | -37.01% |
2022 FY | 81.72 Million CNY | -50.97% |
2022 Q4 | 8.65 Million CNY | 0.0% |
2022 Q3 | 8.65 Million CNY | -73.13% |
2021 Q1 | 32.2 Million CNY | 0.0% |
2021 FY | 166.67 Million CNY | 13.97% |
2021 Q4 | 51.13 Million CNY | 0.0% |
2021 Q3 | 51.13 Million CNY | 58.77% |
2021 Q2 | 32.2 Million CNY | 0.0% |
2020 FY | 146.24 Million CNY | 86.35% |
2019 FY | 78.47 Million CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Life Healthcare Group Limited | 37.78 Million HKD | -133.655% |
China Biotech Services Holdings Limited | 34.32 Million HKD | -157.243% |